EUROGIN - International Multidisiplinary HPV Congress

About this event

EUROGIN – International Multidisciplinary HPV Congress (EUROGIN)

Overview

EUROGIN is positioned as the leading international congress focused on HPV infections and associated cancers, with a clear mission to translate scientific and evidence-based research into clinical practice. The program spans research-oriented scientific sessions as well as clinically oriented sessions intended to help participants integrate knowledge into day-to-day practice.

Dates & Location

• Dates: Feb. 10–13, 2027
• Venue: Bologna Congress Center
• City/Country: Bologna, Italy

Event Type

This is a medical/scientific congress with a multidisciplinary structure combining:

• Scientific sessions covering HPV infections and related diseases, including screening and prevention
• Clinical sessions designed to help participants apply learning in everyday practice
• Free communications for sharing latest research with a global professional audience

1) Who Attends (Buyers / Attendees)

EUROGIN is not a consumer-focused event; it is a qualified healthcare and research audience congress. The “buyer” layer is best understood as the decision-makers who influence research direction, clinical guideline uptake, screening/prevention implementation, and technology adoption in HPV-related care pathways.

Primary attendee groups (high-likelihood buyer personas):

• Clinical decision-makers: gynecologists, oncologists, infectious disease specialists, screening program leaders, and other clinicians working in HPV-related prevention and early diagnosis
• Academic & research leaders: principal investigators, study directors, clinical researchers, and poster/oral presenters across HPV epidemiology, prevention, diagnostics, and patient outcomes
• Screening & public health stakeholders: professionals involved in cervical cancer screening strategies, HPV prevention programs, and early detection pathways
• Laboratory and diagnostics stakeholders: clinical lab professionals, translational research teams, and diagnostic implementation specialists (especially around screening methods and HPV testing approaches)
• Industry-facing professionals (sponsors/exhibitors): representatives from medical technology, diagnostics, and related healthcare innovation companies (typically concentrated in sponsor/exhibit roles rather than general attendees)
• Conference contributors: authors, poster presenters, and those participating via abstract formats (which often correlate with organizational research/clinical influence)

2) Where the Show Is Happening + Attendee Geographic Origin

Show location: Bologna Congress Center, Bologna, Italy (Feb. 10–13, 2027).

Expected geographic pattern:

• The congress is explicitly international, with attendees coming from 90 countries (as stated in the event’s facts & figures).
• Since the event is held in Italy, there will likely be a strong European presence, but the stated footprint indicates it is designed to attract global participation.

For outreach purposes, the most practical geographic targeting is:

• Europe-first (short travel, strong alignment with screening/public health programs)
• Global secondary layer (countries represented through the 90-country attendance)

3) Audience Reach (Local / National / Global)

EUROGIN’s audience reach is best categorized as global. The event reports:

• 90 countries represented
• 1,600+ participants

4) Sample Buyer Company Names (BUYERS ONLY) + Websites

We can provide buyer-focused company targets, but we need one more input to ensure we match your client’s exact needs and product category (see Section 8 below).

Until we receive that, below are buyer-leaning sample target types and example organizations commonly connected to HPV prevention, screening, diagnostics, and clinical technology ecosystems. Use these as starting points for research and prioritization.

Note: We intentionally kept the list “buyer-leaning” and aligned to the congress themes. After you share your client website and product category, we will produce a much tighter, higher-conversion buyer list (titles + priorities + matching companies).

5) Job Profiles, Industries & Event Type

High-value job profiles to target:

• Medical Directors (vaccines, women’s health, clinical strategy)
• Clinical Affairs / Medical Affairs leadership (evidence, study communication, adoption)
• Head of Clinical Programs and Clinical Research Directors
• VP/Director Product Management (HPV testing, women’s health diagnostics)
• Market Access / Public Health Program Leaders (screening & prevention ecosystem)
• Diagnostics/Pathology Laboratory Directors (implementation, validation workflows)
• Screening Program Directors (cervical cancer screening pathway roles)
• Academic/Research Principal Investigators (poster/oral presenter leadership roles)
• Business Development / Partnerships (clinical collaborations, site network expansion)

Industries most associated with this event’s buyer intent:

• Pharmaceuticals (HPV prevention and associated clinical research)
• Medical Devices (women’s health and related clinical solutions)
• Medical/Healthcare providers and research institutions (clinical and scientific adoption)
• Diagnostics / Clinical laboratories / Translational research tooling
• Hospital & Health Care (screening program leadership and clinical pathway implementers)
• Research and Program Development (evidence generation and education)
• Events Services is present through sponsorship/exhibition logistics, but buyer intent typically concentrates in clinical/science stakeholders rather than pure event vendors

Event type (what participants come for):

• International medical/scientific congress
• HPV research dissemination + prevention/diagnostics advancement
• Clinical integration sessions (practical application)
• Abstracts and posters for latest findings

6) Estimated Attendance (Expected Total Footfall)

EUROGIN reports 1,600+ participants and 660+ speakers / poster presenters, along with 725 oral presentations.

For planning outreach expectations, the best stated indicator for footfall is the 1,600+ participant figure.

7) Key Focus Areas & Buyer Engagement

Core scientific/clinical focus areas:

• HPV infections and related diseases
• Screening (including prevention-linked detection approaches)
• Prevention strategies and public health direction
• Diagnostics integration into clinical practice
• Clinical translation from research into day-to-day clinical workflows
• Free communications to share the newest research findings globally

Best buyer engagement angles (what resonates with decision-makers):

• Evidence and outcomes: emphasize clinical utility, study data, and implementation evidence
• Prevention pathway support: connect to screening and prevention program adoption
• Clinical workflow relevance: highlight how products/solutions reduce time-to-action in screening/diagnostics
• Global collaboration: align with an international network of researchers and clinicians (the event explicitly draws 90 countries)
• Educational impact: address clinical session learning and integration into practice

8) Client Product Review (We need your client website)

To determine the best buyer types and priority companies for your specific requirement, we need your client website. Please share the website URL so we can map your offering to the most relevant buyer segment and produce a prioritized list of buyer companies and job titles.

What we will do once you share the website:

• Identify whether your product is strongest in vaccines / pharma, diagnostics, medical devices, clinical workflow tools, or services
• Translate that into buyer job profiles (clinical affairs, medical directors, product management, screening program leadership, etc.)
• Select companies that are the closest match to your product category and typical buyer behavior at congresses
• Return an upgraded buyer list with Priority, Company, Website, Best Title to Target, and Why This is a Good Buyer Fit

If you paste the website here, we can proceed with the buyer prioritization immediately.

9) Recommended Industry Targeting (from your industry taxonomy)

Based on the congress topic (HPV prevention, screening, diagnostics, clinical translation), the most relevant industry categories to prioritize are:

• Pharmaceuticals
• Medical Devices
• Hospital & Health Care
• Research
• Biotechnology
• Medical Practice
• Program Development
• Education Management (only where clinical education/programming is part of the company’s offering)
• Events Services (only for sponsor/exhibit agencies—usually not the primary clinical buyer persona)

Data Points We Can Reliably Use From the Event Source

• Date: Feb. 10–13, 2027
• Venue: Bologna Congress Center
• City/Country: Bologna, Italy
• Participants: 1,600+ participants
• Countries represented: 90 countries
• Speakers / poster presenters: 660+
• Oral presentations: 725

Next Step

Please share your client website and a 1–2 sentence description of what your client sells. We will then produce a tighter buyer list aligned to the congress’s HPV prevention/screening/diagnostics ecosystem, including a 15–20 row sample table with the columns: Priority, Company, Website, Best Title to Target, Why This is a Good Buyer Fit.